Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ISLA-101
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : State University of New York
Deal Size : Not Applicable
Deal Type : Not Applicable
Island Pharmaceuticals Granted Key Patent for ISLA-101 in the United States
Details : ISLA-101, has been granted by the United States Patent & Trademark Office. ISLA-101 is a drug with a very well-known safety profile, being repurposed for mosquito borne viruses.
Brand Name : ISLA-101
Molecule Type : Undisclosed
Upfront Cash : Not Applicable
May 19, 2021
Lead Product(s) : ISLA-101
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : State University of New York
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?
Reset All
